Saturday, December, 15, 2018 12:25:58

Category: Health

Merck rolls out BioContinuum platform to advance drug manufacturing

U.S. based pharmaceutical company Merck has reportedly launched its BioContinuum Platform in an attempt to advance the production of biotherapeutic drugs through improved efficiency, greater quality and consistency as well as simplified plant operations. This expanded offering was introduced by the company at the 2018 …

U.S. FDA approves Pfizer Inc’s lung cancer medicine LORBRENA®

Pfizer Inc., the New York-based pharmaceutical company, has reportedly announced that its third-generation lung cancer drug LORBRENA has been approved by the U.S. Food & Drug Administration (FDA). Reports cite, the drug – an ALK TKI (Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor) – is designed …

Roche & Wellthy Therapeutics to introduce AI-based diabetes coaching

Leading drug firm Roche has reportedly formed a partnership with India’s Wellthy Therapeutics to provide its users with the Accu-Check Active system, an artificial intelligence-related digital diabetes coaching solution. As per trusted sources, the joint offering of the two companies will include the Accu-Check Active …

TherapeuticsMD receives FDA approval for drug to treat hot flashes

TherapeuticsMD, Inc., an innovative pharmaceutical company, committed to advance women’s healthcare, recently announced that its BIJUVA™ (estradiol and progesterone) capsules have been approved by the United States Food and Drug Administration (FDA). BIJUVA is the first oral capsule that has been approved by the FDA …

Cipla acquires USFDA approval for its hypertension, cardiac drug

Indian pharmaceutical and biotechnology conglomerate, Cipla Limited, has recently announced receiving a final approval for marketing its Metoprolol ER tablets from the United States Food and Drug Administration (USFDA). Sources close to the matter state that Cipla, at its recent BSE (Bombay Stock Exchange) filing, announced …